
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Endo and Mallinckrodt—two drugmakers that have run into financial rough spots in recent years—will merge in a stock and cash transaction worth $6.7 billion, the companies formally announced Thursday. The news comes after reports of a business combination …